Could a new tracer reveal hidden brain inflammation in MS?

NCT ID NCT07115017

Recruiting now Knowledge-focused Sponsor: Washington University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Aug 05, 2026 · Updated 3 times

Summary

This study tests a new radioactive tracer called [18F]FZTA to see if it can spot inflammation in the brain using PET scans. Researchers will compare 80 people—some with Multiple Sclerosis and some healthy—to see if the tracer lights up differently in those with MS. The goal is to improve how we detect and understand inflammation in the brain.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: [18F]FZTA (a radioactive tracer for PET scans)
What this could lead to: If successful, this could lead to a better way to see inflammation in the brain, helping doctors understand and monitor Multiple Sclerosis.
What could go wrong: This is an early imaging study, not a treatment. The tracer may not clearly distinguish MS from healthy brains, and results may not change patient care directly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE SCLEROSIS

Contacts and locations

Locations

Washington University in St. Louis
RECRUITING

St Louis, Missouri, 63110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.